Aelis Farma S.A.
AELIS.PA · PAR
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Revenue | €895 | €1,438 | €4,124 | €5,320 |
| % Growth | -37.8% | -65.1% | -22.5% | – |
| Cost of Goods Sold | €131 | €3,330 | €0 | €0 |
| Gross Profit | €895 | €1,438 | €4,124 | €6,657 |
| % Margin | 100% | 100% | 100% | 125.1% |
| R&D Expenses | €3,702 | €4,636 | €6,115 | €9,061 |
| G&A Expenses | €1,339 | €1,682 | €1,673 | €1,615 |
| SG&A Expenses | €1,339 | €1,682 | €1,675 | €1,504 |
| Sales & Mktg Exp. | €0 | €0 | €2 | €0 |
| Other Operating Expenses | -€1 | -€810 | -€1 | €0 |
| Operating Expenses | €5,040 | €5,508 | €7,789 | €10,565 |
| Operating Income | -€4,145 | -€4,070 | -€3,665 | -€5,356 |
| % Margin | -463.1% | -283% | -88.9% | -100.7% |
| Other Income/Exp. Net | -€174 | €5,406 | -€5,119 | €1,196 |
| Pre-Tax Income | -€4,319 | €1,336 | -€8,784 | -€4,160 |
| Tax Expense | €4 | €8 | -€5,201 | -€715 |
| Net Income | -€4,323 | -€3,873 | -€3,583 | -€3,445 |
| % Margin | -483% | -269.3% | -86.9% | -64.8% |
| EPS | -0.32 | -0.28 | -0.27 | -0.26 |
| % Growth | -14.3% | -3.7% | -3.8% | – |
| EPS Diluted | -0.32 | -0.28 | -0.27 | -0.26 |
| Weighted Avg Shares Out | 13,666 | 13,705 | 13,224 | 13,258 |
| Weighted Avg Shares Out Dil | 13,666 | 13,705 | 13,224 | 13,258 |
| Supplemental Information | – | – | – | – |
| Interest Income | €0 | €298 | €195 | €271 |
| Interest Expense | €131 | €121 | €104 | €84 |
| Depreciation & Amortization | €43 | -€1,470 | €128 | €111 |
| EBITDA | -€4,104 | -€4,458 | -€3,538 | -€3,964 |
| % Margin | -458.5% | -310% | -85.8% | -74.5% |